ChroMedX Announces HemoPalm Trademark and Intellectual Property Update

Oct 24, 2014 (Al Bawaba Business via COMTEX) Toronto, Ontario (Newsfile Corp. October 23, 2014) ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (Frankfurt: EIY2) (the Company ), a developer of in vitro diagnostics and point-of-care technologies is pleased to announce that the trademark for the Company s patented HemoPalm technology has been allowed by the United States Patent and Trademark Office and will be officially registered when the HemoPalm is released commercially. The HemoPalm technology is currently covered by two issued and one pending patent. The pending patent will be filed internationally in spring 2015, with the intent to extend the patent protection term in the US, and to seek patent protection at least in Europe and Asia for the extended term. ChroMedX continues to build on a strong foundation of intellectual property detailing the Company s novel in-vitro diagnostic and point-of-care testing systems. We are pleased to make this announcement and look forward to the official r
http://bit.ly/1shXZJO